PEPTIDE VACCINATION AGAINST CANCER TESTIS ANTIGENS IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME AND ACUTE MYELOID LEUKEMIA: AN ONGOING PHASE I STUDY

被引：0
|
作者：
Holmberg, S. [1 ]
Gang, A. Ortved [1 ]
Svane, I. M. [2 ]
Dufva, I. Hogh [1 ]
Hadrup, S. Reker [3 ]
机构：
[1] Herlev Hosp, Dept Hematol, Herlev, Denmark
[2] Herlev Hosp, Ctr Canc Immune Therapy, Herlev, Denmark
[3] Tech Univ Denmark, Sect Vaccinol & Immunol, Copenhagen, Denmark
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1915
引用
收藏
页码：771 / 772
页数：2
相关论文
共 50 条
  • [31] Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia
    Kobayashi, Yukio
    Munakata, Wataru
    Ogura, Michinori
    Uchida, Toshiki
    Taniwaki, Masafumi
    Kobayashi, Tsutomu
    Shimada, Fumika
    Yonemura, Masataka
    Matsuoka, Fumiko
    Tajima, Takeshi
    Yakushijin, Kimikazu
    Minami, Hironobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (01) : 83 - 91
  • [32] Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia
    Yukio Kobayashi
    Wataru Munakata
    Michinori Ogura
    Toshiki Uchida
    Masafumi Taniwaki
    Tsutomu Kobayashi
    Fumika Shimada
    Masataka Yonemura
    Fumiko Matsuoka
    Takeshi Tajima
    Kimikazu Yakushijin
    Hironobu Minami
    International Journal of Hematology, 2018, 107 : 83 - 91
  • [33] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Attar, Eyal C.
    Amrein, Philip C.
    Fraser, James W.
    Fathi, Amir T.
    McAfee, Steven
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Stone, Richard M.
    Foster, Julia
    Neuberg, Donna
    Ballen, Karen K.
    LEUKEMIA RESEARCH, 2013, 37 (09) : 1016 - 1020
  • [34] Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Amrein, Philip C.
    Attar, Eyal C.
    Fathi, Amir Tahmasb
    McAfee, Steven L.
    Wadleigh, Martha
    DeAngelo, Daniel J.
    Steensma, David P.
    Foster, Julia
    Stone, Richard M.
    Neuberg, Donna S.
    Ballen, Karen K.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [35] Phase I Study of Vorinostat in Combination with Decitabine in Patients with Relapsed or Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
    Kirschbaum, Mark
    Gojo, Ivana
    Goldberg, Stuart L.
    Kujawski, Lisa
    Atallah, Ehab
    Marks, Peter
    Garcia-Vargas, Jose
    Rizvi, Syed
    Di Gravio, Donna
    Ahern, Janet
    Issa, Jean-Pierre
    BLOOD, 2008, 112 (11) : 1250 - 1250
  • [36] Phase I study of azacitidine and bortezomib in adults with relapsed or refractory acute myeloid leukemia
    Walker, Alison R.
    Klisovic, Rebecca B.
    Garzon, Ramiro
    Schaaf, Larry J.
    Humphries, Kristina
    Devine, Steven M.
    Byrd, John C.
    Grever, Michael R.
    Marcucci, Guido
    Blum, William
    LEUKEMIA & LYMPHOMA, 2014, 55 (06) : 1304 - 1308
  • [37] Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study
    Merkel, Drorit
    Filanovsky, Kalman
    Gafter-Gvili, Anat
    Vidal, Liat
    Aviv, Ariel
    Gatt, Moshe E.
    Silbershatz, Itay
    Herishanu, Yair
    Arad, Ariela
    Tadmor, Tamar
    Dally, Najib
    Nemets, Anatoly
    Rouvio, Ory
    Ronson, Aharon
    Herzog-Tzarfati, Katrin
    Akria, Luiza
    Braester, Andrei
    Hellmann, Ilana
    Yeganeh, Shay
    Nagler, Arnon
    Leiba, Ronit
    Mittelman, Moshe
    Ofran, Yishai
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (02) : 130 - 134
  • [38] A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia
    Medeiros, Bruno C.
    Tanaka, Tiffany N.
    Balaian, Larisa
    Bashey, Asad
    Guzdar, Amy
    Li, Hongying
    Messer, Karen
    Ball, Edward D.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (05): : 346 - +
  • [39] Results of a phase I/II study of the combination of 5-aza-2′-deoxycytidine and valproic acid in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Garcia-Manero, G
    Kantarjian, H
    Sanchez-Gonzalez, B
    Verstovsek, S
    Ravandi, F
    Ryttling, M
    Cortes, J
    Yang, H
    Fiorentino, J
    Rosner, G
    Issa, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 571S - 571S
  • [40] Update of a phase I study of sorafenib in patients with refractory/relapsed acute myeloid leukemia or high-risk myelodysplastic syndrome
    Delmonte, John, Jr.
    Kantarjian, Hagop M.
    Andreef, Michael
    Faderl, Stefan
    Wright, John J.
    Zhang, Weiguo
    Konopleva, Marina
    Verstovsek, Srdan
    Borthakur, Gautam
    Ravandi, Farhad
    Cortes, Jorge
    BLOOD, 2007, 110 (11) : 272A - 273A
12345